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Objectives. To demonstrate that hand-assisted laparoscopy for aortofemoral bypass for severe aorto-iliac occlusive disease
reduces morbidity with earlier recovery of bowel function and shorter in-hospital stay.
Design. Randomised controlled trial.
Materials and methods. Thirty-six consecutive patients with severe aorto-iliac occlusive disease (TASK C/D) without
history of major abdominal surgery necessitating an aortobifemoral bypass were randomised between a hand-assisted lap-
aroscopic (HALS) approach and a conventional medial laparotomy. Operative data, early recovery data, quality of life and
vascular outcome were analysed.
Results. No significant differences in operative data were found. Fluid and solid diet were resumed earlier (28.8 hrs vs.
76.9 hrs; p¼ 0.016) (45.6 hrs vs. 105.6 hrs; p¼ 0.02) and in-hospital stay was shorter (7.5 vs. 8.9 days; p¼ 0.005) in
the HALS group. Six weeks post-operatively social functioning measured by the SF-36survey score was better in patients
randomised to HALS (p¼ 0.023).
Conclusions. HALS is a less invasive approach for aortofemoral bypass.
Keywords: Aorto-iliac occlusive disease; Aortobifemoral graft; Minimal-invasive; Minimal-access; Hand-assisted
laparoscopy.Introduction
The treatment of aorto-iliac occlusive disease has
changed dramatically with the introduction of percu-
taneous angioplasty and stenting. However, accord-
ing to the TransAtlantic Inter-Society Consensus
(TASC) for severe aorto-iliac disease (TASC D) aorto-
bifemoral bypass remains the therapy of choice. For
TASC C lesions definitive recommendations must
await more convincing evidence, but also for these
lesions the preferred therapeutic option tends towards
aortobifemoral bypass.1
Operative mortality and morbidity rates are tradi-
tionally cited as the major drawback of direct aortic
reconstruction.2,3 However, it has been well docu-
mented that morbidity can be influenced by the sur-
gical approach.4,5 Therefore, in analogy with the
good results of laparoscopic abdominal procedures,
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But totally laparoscopic and even laparoscopically as-
sisted aortic surgery remains technically demanding.
To minimize the learning curve and in anticipation of
increasing surgical experience and better instrumen-
tation that will make advanced totally laparoscopic
surgery feasible for every surgeon, hand-assisted
laparoscopy (HALS) was successfully introduced.8e10
However, the fact that HALS still requires a mini-
laparotomy with stretched wound edges throughout
the procedure aroused scepticism whether HALS
maintained minimally invasive characteristics. There-
fore, we set up a randomised controlled trial to study
the clinical outcome of HALS aortobifemoral graft for
occlusive disease compared with conventional open
technique.
Materials and Methods
Between January 2003 and January 2004 39 patients
without history of major abdominal surgery were
treated with an aortobifemoral bypass because of se-
vere aorto-iliac occlusive disease (TASC C/D) at ourerved.
646 I. Fourneau et al.university hospital. During the same period 33 pa-
tients were treated with a femorofemoral crossover
bypass or axillofemoral bypass because of contra-
indications for anatomical revascularisation (severe
cardiac dysfunctionwith ejection fraction<30%, severe
pulmonary disease excluding general anesthesia, short
life expectancy). All but 3 of the 39 patients considered
for aortobifemoral bypass were included in the study
and randomised between either hand-assisted laparo-
scopic (HALS) approach or conventional median lapa-
rotomy. The patients not included in the study were
selected for totally laparoscopic bypass. No patients
were excluded from the study for vascular reasons.
Randomisation occurred by alternate allocation from
the order the patient entered thewaiting list. According
to the local legislation at the time of this study no ap-
proval by the ethical committee nor an informed con-
sent of the patient was necessary.
Patients were not required to eat a low residue diet
before surgery. The evening before surgery all patients
recieved bowel preparation.
Before induction of general anesthesia patients in
both groups received an epidural catheter with a
loading dose of chirocaine. Postoperatively, a patient-
controlledepidural analgesia (PCEA)systemwas setup.
As described previously,10 in patients treated by the
HALS approach the femoral arteries were dissected
free in the conventional way through two groin inci-
sions. A supra-umbilical midline incision was made,
the length being determined by the size of the sur-
geon’s hand. Two additional 10 mm trocards were in-
serted, one in the hypogastrium, one in the left iliac
fossa. The minilaparotomy was sealed with a Gelport
(Applied Medical, Rancho Santa Margarita, CA92688,
USA) and a pneumoperitoneum of 12 mmHg was
applied. The patient was put in a 30  Trendelenburg
position and tilted slightly to the right. The dorsal
peritoneum was opened and the infrarenal aorta was
dissected free using a combination of blunt digital dis-
section and harmonic scalpel. Retroperitoneal tunnel-
ing to the groins was performed by blunt digital
dissection. After finishing the dissection the pneumo-
peritoneum was deflated and an orthostatic retractor
was put in place. Through the minilaparotomy, the
aorta was clamped and the proximal anastomosis
was performed using conventional vascular instru-
ments. The graft was pulled to the groins and the distal
anastomoses were performed. After completion of the
distal anastomoses, laparoscopy was performed to in-
spect the abdominal cavity. Special care was taken to
close the dorsal peritoneum over the graft.
The conventional open aortobifemoral bypass was
performed through a midline laparotomy and two
groin incisions.Eur J Vasc Endovasc Surg Vol 32, December 2006Data analysed in this study include patient demo-
graphics (age, gender, body mass index (BMI), cardio-
vascular risk factors, ASA-score, TASC classification,
Fontaine classification), operative data (incision length,
operative time, estimated blood loss, open conversions,
type of proximal anastomosis, complications) and pa-
tient recovery data (time to PCEA removal, time to re-
turn to fluid diet, time to return to solid diet, time to
ambulation, time to discharge). To evaluate differences
in lung function vital capacity and forced expiratory
volume in one second were measured pre-operatively
and on the secondpost-operative day. To evaluate qual-
ity of life all patients were asked to complete a SF-36
survey pre-operatively and 6 weeks post-operatively.
The SF-36 survey is awell validatedhealth status scale
including 36 questions and a standardised scoring
scale measuring eight health concepts: physical func-
tioning, role limitations due to physical health prob-
lems, bodily pain, general health, vitality (energy/
fatigue), social functioning, role limitations due to emo-
tional problems and mental health.11 In the long-term
follow-up special attention was given to graft patency
and incisional hernia.
We hypothesised that HALS would result in reduc-
tion of morbidity, resulting in shorter recovery and
hospitalisation.
The sample size needed to be able to demonstrate
a reduction of in hospital stay of 25% with 80% power
and p¼ 0.05 was calculated in advance using the Alt-
man nomogram. In a historical control group of 50
patients undergoing aortobifemoral bypass by con-
ventional surgery the mean hospital stay was 7.7
days with a standard deviation of 1.99. The calculated
sample size was 30, i.e. fifteen in each group.
Statistical analysis included the unpaired t-test
for data with a normal distribution and the Mann-
Whitney test for data not normally distribution.
Results
Thirty-six patients were included in the study: 18 in
the HALS group and 18 in the conventional open
group. Fig. 1 gives an overview of the study.
The demographics of patients are summarised in
Table 1, for patients who underwent HALS aortobife-
moral bypass or conventional open bypass respec-
tively. There were no significant differences between
these two groups with respect to sex, age, BMI, car-
diovascular risk factors and severity of disease. How-
ever, in the HALS group more patients belonged to
ASA class III (56% vs. 17% in the conventional group).
The operative data are summarised in Table 2.
Operation time, estimated amount of blood loss and
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Fig. 1. Flowchart of the study.body temperature were similar for both groups. The
incision length was shorter in the HALS group (5.4
vs. 24.8 cm; p< 0.0001). In the HALS group one pa-
tient developed a trash foot intra-operatively, no
intra-operative complications occurred in the conven-
tional open group. In the HALS group no conversions
to conventional open surgery were necessary.
When looking at patient recovery data (Table 3),
both fluid and solid diet were resumed significantly
earlier in the HALS group (28.8 vs. 76.9 hrs;
p¼ 0.017) (45.6 vs. 105.6 hrs; p¼ 0.02) and the length
of hospital stay was shortened (7.5 vs. 8.9; p¼ 0.005).
Table 1. Patient demographics
HALS
n¼ 18
Conventional
n¼ 18
Age (mean, (range)) 57.4 (37e76) 60.1 (48e75)
Gender (M/F) (n) 13/5 14/4
BMI (mean, (range)) 23.6 (18.6e28.4) 23.6 (16.5e31.2)
Smoking (n) 17 18
Diabetes (n) 2 3
ASHD (n)a 8 7
Hypertension (n) 7 7
ASA (I/II/III) (n)b 2/6/10 3/12/3
TASC C/D (n) 9/9 8/10
Fontaine II/III/IV (n)c 13/5/0 14/4/0
Pre-operative ankle-brachial
pressure index at rest
(mean, (range))
0.5 (0.1e0.8) 0.5 (0.2e0.7)
a AtheroSclerotic Heart Disease.
b ASA: American Society of Anesthesiologists; ASA 1 denotes
a healthy individual, ASA 2 denotes a mild systemic disease, ASA
3 denotes a severe but not incapacitating disease.
c Fontaine II denotes claudication, Fontaine III denotes rest pain
and Fontaine IV denotes tissue loss.In the HALS group the patient with the trash foot
stayed 26 days for further conservative care of the
foot without major amputation. In both groups one
patient needed prolonged intubation leading to pro-
longed hospitalisations of 25 and 30 days. Excluding
these patients, the median length of stay was reduced
from 7 days in the conventional open group to 5 days
in the HALS group.
Also the PCEA system could be removed earlier in
the HALS group (1.2 days vs. 3.5 days; p< 0.0001).
The decision to remove the PCEA system was taken
when patients did not press for an extra bolus over
the past 12 hours or on the 4th postoperative day.
Three serious post-operative adverse events oc-
curred (8.3%). In the HALS group, one patient (5.6%)
died on the third postoperative day of arrhythmia.
Another patient developed overwhelming pneumonia
Table 2. Operative data
HALS
n¼ 18
Conventional
n¼ 18
p-value
Incision length
(cm, mean (95% CI))
5.4 (5e5.9) 24.8 (22.8e26.7) <0.0001
Type of proximal
anastomosis
(E-to-E/E-to-S) (n)
5/13 3/15
Operation time
(min, mean (95% CI))
207 (190e223) 205 (172e238) 0.915
Estimated blood loss
(ml, mean (95% CI))
794 (399e1190) 642 (478e807) 0.667
Body temperature
at termination
( C, mean (95% CI))
36.4 (36e36.9) 36.5 (36.1e37) 0.574Eur J Vasc Endovasc Surg Vol 32, December 2006
648 I. Fourneau et al.requiring prolonged intubation. In the conventional
open group, one patient developed severe cardio-
pulmonary insufficiency,needingprolonged intubation.
In the HALS group 4 patients did not perform the
post-operative lung function test. In two patients
this was for logistic reasons, in 2 patients (12.5%) ei-
ther the patient or the lung function technician de-
cided the patient was not capable of doing so. In the
conventional group 9 patients did not perform the
post-operative lung function tests. In one patient this
was for logistic reasons, but in 8 patients (47%) the
lung function test was not performed because either
the patient or the lung function technician decided
the patient was not capable of doing so. Delaying the
post-operative lung function test could have reduced
the amount of patients not able to perform the test.
However, when writing the protocol for this study it
was thought that the difference in lung function
would be an early effect. No differences in lung func-
tion could be detected in patients who completed
testing.
Table 4 shows the analysis of the SF-36 survey
scores in both groups 6 weeks after surgery. No signif-
icant difference could be demonstrated except for
social functioning ( p¼ 0.023). Patients 6 weeks after
HALS had a significantly better social functioning
than patients after conventional open surgery.
In the HALS group 2 patients were lost to follow-up
and one patient died in hospital, leaving fifteen pa-
tients for long-term follow-up. The mean follow-up
for these patients was 19.8 months (range 12e32). Of
these patients one patient developed an incisional her-
nia, treated conservatively. One patient experienced
Table 3. Patient recovery data
HALS
n¼ 18
Conventional
n¼ 18
p-value
Time to return
to fluid diet
(hours, mean
(95% CI))
28.8 (16.7e40.7) 76.9 (39.8e114) 0.017
Time to return
to solid diet
(hours, mean
(95% CI))
45.6 (30.9e60.2) 105.6 (57.6e153.6) 0.02
Time to
ambulation
(hours, mean
(95% CI))
41.6 (29.7e53.4) 101.1 (53.7e148.5) 0.019
Time to discharge
(days, mean
(95% CI))
7.5 (3.9e11) 8.9 (6.16e11.7) 0.005
(days, median
(95% CI))
5 (4e6) 7 (6e10)
Time to removal
of PCEA (rev.2)
(hours, mean
(95% CI))
28.2 (22.7e33.8) 72.4 (65.1e79.8) <0.0001Eur J Vasc Endovasc Surg Vol 32, December 2006recurrence of unilateral claudication 11months post-op-
eratively forwhich a correction of the distal anastomosis
was needed. Two patients developed occlusion of one
limb (at 10 months and 26 months respectively). One
of themwas treatedwitha femoro-femoral crossoverby-
pass and one was treated conservatively. The limb-re-
lated assisted primary patency after 1 and 2 years was
96.6% (Fig. 2).
In the conventional group 1 patient was lost to
follow-up, leaving 17 patients for long-term follow-up.
The mean follow-up for these patients was 18.4
months (range 9e29). One patient died 9 months
post-operatively due to myocardial infarction with
a good functioning graft. Two patients developed an
incisional hernia treated conservatively. Two patients
developed recurrence of claudication due to distal
anastomotic problems necessitating an interposition
graft in the groin. One patient developed an occlusion
of one limb (at 18 months) treated with a femoro-
femoral crossover bypass. The calculated limb-related
assisted primary patency after 1 and 2 years was 100
and 95% respectively (Fig. 2).
Table 4. SF-36 survey 6 weeks after surgery
HALS n¼ 12
(mean (95% CI))
Conventional n¼ 9
(mean (95% CI))
p-value
Physical
functioning
47.4 (42.4e52.4) 43.5 (36.6e50.3) 0.382
Role limitation-
physical
37.3 (30.9e43.6) 35.2 (27.4e43.0) 0.702
Bodily pain 44.2 (36.1e46.9) 41.2 (35.1e46.1) 0.464
General health 47.7 (42.9e51.0) 45.8 (41.5e51.5) 0.808
Vitality 43.7 (39.6e48.6) 41.7 (38.4e45.5) 0.508
Social
functioning
47.3 (41.8e50.7) 34.4 (29.8e40.1) 0.023
Role limitation-
emotional
41 (37.6e48.3) 36 (29.7e45.4) 0.554
Mental health 48.8 (46.0e54.9) 43.1 (39.6e47.7) 0.219
Fig. 2. Kaplan-Meier Curve of limb related primary assisted
patency.
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Our initial experience suggested patient advantages
of HALS over conventional aortic bypass, such as
early return to oral diet and ambulation and short
in-hospital stay.10 This was in accordance with the
findings in other studies.8,11e15 In order to clarify
this with a higher level of evidence a prospective ran-
domized study comparing HALS with conventional
open aorto-iliac reconstruction was required.
All consecutive patients with severe aorto-iliac oc-
clusive disease TASC C or D and without history of
previous major abdominal surgery were considered
for randomisation.
Patients with a history of abdominal surgery were
excluded to improve the homogeneity of study
groups as longer operation times can be expected in
these patients. No patients were excluded for vascular
reasons as the vascular indications are the same for
both approaches.
The absence of differences in operative data in both
study groups is in accordance with earlier findings
that HALS is feasible for the average vascular surgeon
without a steep learning curve.9,10,12,14 To interpret the
operation time more correctly, it should be mentioned
that in half of the patients we had to deal with redo-
groin dissection and that in all patients the distal
anastomosis was performed end to side on the com-
mon femoral artery extending several centimetres
into the profunda femoris artery.
We found an earlier return to fluid and solid diet,
earlier ambulation and a shorter in-hospital stay for pa-
tients treated byHALS. For practical reasons it was not
possible to blind assessment in this study. However,
we believe that any bias introduced because of this
favoured the conventional group. We believe that
normal ward practises would likely have made it more
difficult to detect difference in the outcome of HALS
and conventional surgery. For example, as the nursing
staff were familiar with a much slower post-operative
recovery patients in the HALS group were generally
discouraged from early ambulation and diet intake.
We also found a significantly earlier removal of the
PCEA system, reflecting a reduction in need for anal-
gesia. Most of the PCEA systems in the HALS group
could be removed within the first postoperative day
suggesting that this form of analgesia may not be re-
quired for these patients. However, the epidural cath-
eter is a major adjunctive during anesthesia for aortic
surgery improving the outcome.16
No differences in lung function were found. This
finding may have been affected by the timing of the
assessment and the number of patients unable to com-
plete the tests. Forty-seven percent of patients in theconventional group were not able to complete spirom-
etry compared to 12% of the HALS group. This find-
ing suggests that patients were more physically
recovered from surgery in the HALS group.
Analysis of the SF-36 survey score 6 weeks post-
operatively showed significant better social function-
ing in patients after HALS than after conventional
open surgery. We expected to identify differences in
other domains of the assessment. While the SF-36 is
recognised as a good generic measure of quality of
life we may have failed to detect differences which
would have been identified by a disease-specific
questionnaire.
A concern of the HALS approach is the continuous
stress on the wound edges throughout the procedure,
which may influence wound healing. However, in
contrast with the experience of some urologists, no
early wound healing problems at the site of the mini-
laparotomy were seen.17 Similarly the incidence of
incisional hernia was only 6.7% in the HALS group.
We recently published the midterm results of a series
of 45 patients receiving aortobifemoral bypass by
HALS approach and in that series the incidence of
incisional hernia was 19.5%.4,10 The use of a polypro-
pylene mesh could be considered in patients following
HALS.18
The assisted primary graft patency was 97.5%
at 1 and 2 years in the HALS group and 100% and
95% respectively in the conventional open group.
The similarlity in outcome suggests that the limited
access in HALS did not reduce the technical success
of the procedure.
Limitations of the Study
It should be noticed that this study has limitations
due to some methodological flaws.
First, a concern of duplicated publication could
be raised as we recently published the early and
mid-term results of HALS aortobifemoral bypass for
aorto-iliac occlusive disease in 46 patients, including
the 18 patients of the HALS group in this study.10
However, the data of these 18 patients are analysed
much more extensively in this study (including
lung-function, need for analgesia, SF-36 survey, longer
follow-up) and the comparison with data of the pa-
tients in the conventional group adds a lot of value.
The previous published series was published as a pro-
spective survey, intending to report our complete
experience with the HALS technique, including the
patients from our first non-randomised experience
as well as the patients from our later randomised
experience.Eur J Vasc Endovasc Surg Vol 32, December 2006
650 I. Fourneau et al.Second, the atypical randomisation method of al-
ternate allocation could raise the fear for bias. We
are aware of the weakness in methodology, but, as
the order of entering the waiting list, determined by
the administration, was respected, the risk of bias
was rather low. That this type of randomisation did
not cause any bias is illustrated by the fact that patient
demographics are quite comparable in both groups.
The differences in ASA scores between groups, fav-
oured the conventional group. This type of random-
isation was chosen for logistic reasons.
Third, the sample size of 18 patients in each group
was small. However, a sample size calculation was
performed in advance to determine the sample size
needed as mentioned above. The calculated needed
sample size was 30, i.e. fifteen in each group.
Conclusion
HALS aorto-femoral reconstructions is a minimal ac-
cess surgical technique without a steep learning
curve. According to the results of this study HALS
is associated with a more rapid recovery of bowel
function and shorter in-hospital stay. HALS should
be considered an option for aortic bypass when total
laparoscopic repair is considered appropriate but
not feasible.
Preliminary results of this study have been pre-
sented at the 2nd International Endovascular Laparos-
copy Congress, Que´bec City, Canada in May 2004 and
at the Controversies and Update in Vascular Surgery
Meeting, Paris, France in January 2005. ‘Controversies
and updates in Vascular Surgery, January 2005,
Paris.19,20
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